Could COX-2 Inhibition With Celecoxib Have Role in Breast Cancer?
Published: | Updated:
This video highlights results of REACT, a phase III multi-center double-blind randomized trial of celecoxib vs placebo in patients with breast cancer.
R. Charles Coombes, MD, PhD
Advertisement
Articles by R. Charles Coombes, MD, PhD
Advertisement
Latest Updated Articles
Could COX-2 Inhibition With Celecoxib Have Role in Breast Cancer?Published: January 8th 2018 | Updated: November 11th 2020
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Grants Accelerated Approval to Zongertinib in HER2+ NSCLC
2
Enfortumab Vedotin Combo Boosts MIBC Survival Outcomes in EV-304 Trial
3
ctDNA Clearance Correlates With Improved Metastasis-Free Survival in MIBC
4
The Complexity of Insurance for Patients with Cancer in Community Settings
5